Stuart D. Aronson
Thank you, Rob. Good afternoon, everyone. Thank you for joining us today. As you're aware, we issued our earnings this morning before the market opened, and I hope you've had a chance to review our results for the period ended June 30, 2025, which can also be found on our website. On today's call, I will begin by addressing our second quarter results and current market conditions. Joyson Thomas, our Chief Financial Officer, will then discuss our performance in greater detail, after which, we will open the floor for questions. Our results for the second quarter of 2025 were disappointing as our investment portfolio declined this quarter due to net realized and unrealized losses, which impacted our financial performance. Q2 GAAP net investment income and core NII was $6.6 million or $0.282 per share compared with a quarterly distribution of $0.385 per share and was below the Q1 GAAP and core NII of $6.8 million or $0.294 per share. NAV per share at the end of Q2 was $11.82 representing a 2.4% decrease from the prior quarter. NAV per share was impacted by net realized and unrealized losses in our portfolio that totaled $4.3 million. Turning to our portfolio activity in Q2. We had gross capital deployments of $39 million, which was partially offset by total repayments and sales of $36.2 million, resulting in net deployments of $2.8 million. Gross capital deployments consisted of 3 new originations totaling $33.1 million and the remaining $5.9 million was used to fund 3 add-ons to existing investments. In addition, there was $0.3 million in net fundings made on revolver commitments. Of our 3 new originations in Q2, 1 was nonsponsor and 2 were sponsor deals with an average leverage of approximately 4x EBITDA. All of our Q2 deals were first lien loans at an average spread of 560 basis points and average all-in rate of 9.9% compared to 9.6% in the first quarter of 2025. Total repayments and sales were $36.2 million, primarily driven by complete realizations in our positions in CleanChoice and Flexitallic. At the end of Q2, 99.3% of our debt portfolio was first lien senior secured, and our portfolio mix was approximately 2/3 sponsor and 1/3 non-sponsor. During the quarter, the BDC transferred 3 new deals and 1 existing investment to the STRS JV. At the end of Q2, the STRS JV total portfolio had an aggregate fair value of $330 million at an average effective yield on the JV's portfolio of 10.6% compared to 10.8% in Q1. Leverage for the JV at the end of Q2 was 1.16x compared with 0.98x at the end of the first -- the prior quarter. We continue to successfully utilize the JV and believe WhiteHorse's equity investment in the JV continues to provide attractive returns for our shareholders. After net deployment, JV transfers and net realized and unrealized losses, total investments decreased by $21.7 million from the prior quarter to $629.3 million. This compares to our portfolio's fair value of $651 million at the end of Q1. The weighted average effective yield on our income- producing debt investments decreased to 11.9% at the end of Q2, compared to 12.1% in the first quarter of 2025. The weighted average effective yield on our overall portfolio increased slightly to 9.8% at the end of Q2 compared to approximately 9.6% at the end of Q1, primarily driven by Telestream returning to accrual status and the realization of American Crafts. During the quarter, we took net write-downs of $3.6 million primarily driven by write-downs in Honors Holdings and Aspect Software. As I mentioned earlier, American Crafts has now been fully resolved, eliminating any further downside from that investment. No credits replaced on nonaccrual in Q2 and nonaccrual investments totaled 4.9% of the debt portfolio, an improvement compared with 8.8% of the net portfolio at fair value in the prior quarter. As I mentioned earlier, Telestream returned to accrual status this quarter, which will benefit the BDC's earnings capacity going forward. We also expect that a portion of MSI information services will likely go back on accrual in the third quarter, subject to a successful restructuring of the debt. Other deals on nonaccrual are likely to remain that way for some period of time. We are continuing to actively work on getting deals off nonaccrual, leveraging the expertise of our 5-person dedicated restructuring team and the resources of HIG Capital. Aside from credits on nonaccrual, our portfolio is performing well. We have performed subsequent tariff analysis across the portfolio, and we believe that less than 10% of the portfolio is either heavily or moderately exposed to tariffs. Turning to the lending market. M&A activity remains pretty subdued due in part to tariff uncertainty, and this has led to reduced supply of new financing deals in the market. At the same time, there is plenty of capital available from other lenders. This has created unprecedented competition for companies doing financings particularly for companies that are noncyclical and do not have meaningful international sales exposure. In the upper mid-cap and large-cap markets, deals are typically pricing at SOFR 4.25% to SOFR 4.75%. and, in many cases, on highly adjusted EBITDA levels. Leverage multiples in that sector are between 6 and 8x and deals are getting structured with partial pick to make the cash flows work on the deals. That is not nearly as true in the middle market where we focus, where pricing is 50 basis points higher at between SOFR 4.75% to SOFR 5.25%. Most of the deals we see are getting down at leverage of between 4 to 6x and most deals still have covenant protection. And the lower mid-market pricing is very similar to the mid-market with pricing starting at SOFR 4.75% but more often being at 5.00% or 5.25% and extending to as high as 5.75% for more complex or cyclical credits. These prices and structures are for the sponsor market, The nonsponsor market remains much less competitive. We continue to focus significant resources on the nonsponsor market where there are better risk returns in many cases and much less competition than what we're seeing in the new on-the-run sponsor market. We currently have 24 originators covering 13 local regional markets. Given market conditions, these originators are primarily focused on sourcing off-the-run sponsor deals for smaller private equity firms and nonsponsor deals as we look for value in the market where there is limited deal flow and a lot of aggressiveness. To put the attractiveness of the nonsponsor market in context, our nonsponsor mandates are still levered only 3 to 4.5x and the highest priced deal we have priced recently is at SOFR 7.00% with all the other deals being SOFR 6.00% or better. Subsequent to quarter end, the BDC has closed 2 new investments of $14.4 million and had 1 full repayment totaling $9.6 million. There were 2 existing investments fully transferred to the JV totaling $8 million following the deployment activity in Q2 and pro forma for several transactions that have closed or that we expect to close in Q3 of 2025. The BDC balance sheet has very little capacity for new assets. The JV on the other hand, has approximately $20 million of capacity supplementing the BDC's existing capacity. Our overall sourcing is being impacted by the muted M&A activity, and our pipeline is lower than normal for this time of the year. We currently have 6 new mandates and are working on 2 add-ons to existing deals. Our 6 mandates comprise 3 sponsor deals and 3 nonsponsor deals. While there can be no assurance that any of these deals will close, all of these deals should fit into the BDC or our JV should we elect to transact. With that, I'll turn the call over to Joyson for additional performance details and a review of our portfolio composition. Joyson, go ahead.